HEADER VIRAL PROTEIN 26-JAN-22 7WR9 TITLE LOCAL CRYOEM STRUCTURE OF THE SARS-COV S2P IN COMPLEX WITH BD55-3152 TITLE 2 FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: BD55-3152H; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BD55-3152L; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: F; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; SOURCE 13 ORGANISM_TAXID: 2901879; SOURCE 14 GENE: S, 2; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ANTIBODY, COMPLEX, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.DU,J.Y.XIAO REVDAT 1 01-FEB-23 7WR9 0 JRNL AUTH S.DU,J.Y.XIAO JRNL TITL LOCAL CRYOEM STRUCTURE OF THE SARS-COV S2P IN COMPLEX WITH JRNL TITL 2 BD55-3152 FAB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.240 REMARK 3 NUMBER OF PARTICLES : 222513 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7WR9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1300027291. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : THE SARS-COV S2P IN COMPLEX REMARK 245 WITH BD55-3152 FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.20 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : DARK FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, F, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 GLY A -17 REMARK 465 TRP A -16 REMARK 465 SER A -15 REMARK 465 LEU A -14 REMARK 465 ILE A -13 REMARK 465 LEU A -12 REMARK 465 LEU A -11 REMARK 465 PHE A -10 REMARK 465 LEU A -9 REMARK 465 VAL A -8 REMARK 465 ALA A -7 REMARK 465 VAL A -6 REMARK 465 ALA A -5 REMARK 465 THR A -4 REMARK 465 ARG A -3 REMARK 465 VAL A -2 REMARK 465 LEU A -1 REMARK 465 SER A 0 REMARK 465 SER A 128 REMARK 465 SER A 129 REMARK 465 ALA A 130 REMARK 465 SER A 131 REMARK 465 THR A 132 REMARK 465 LYS A 133 REMARK 465 GLY A 134 REMARK 465 PRO A 135 REMARK 465 SER A 136 REMARK 465 VAL A 137 REMARK 465 PHE A 138 REMARK 465 PRO A 139 REMARK 465 LEU A 140 REMARK 465 ALA A 141 REMARK 465 PRO A 142 REMARK 465 SER A 143 REMARK 465 SER A 144 REMARK 465 LYS A 145 REMARK 465 SER A 146 REMARK 465 THR A 147 REMARK 465 SER A 148 REMARK 465 GLY A 149 REMARK 465 GLY A 150 REMARK 465 THR A 151 REMARK 465 ALA A 152 REMARK 465 ALA A 153 REMARK 465 LEU A 154 REMARK 465 GLY A 155 REMARK 465 CYS A 156 REMARK 465 LEU A 157 REMARK 465 VAL A 158 REMARK 465 LYS A 159 REMARK 465 ASP A 160 REMARK 465 TYR A 161 REMARK 465 PHE A 162 REMARK 465 PRO A 163 REMARK 465 GLU A 164 REMARK 465 PRO A 165 REMARK 465 VAL A 166 REMARK 465 THR A 167 REMARK 465 VAL A 168 REMARK 465 SER A 169 REMARK 465 TRP A 170 REMARK 465 ASN A 171 REMARK 465 SER A 172 REMARK 465 GLY A 173 REMARK 465 ALA A 174 REMARK 465 LEU A 175 REMARK 465 THR A 176 REMARK 465 SER A 177 REMARK 465 GLY A 178 REMARK 465 VAL A 179 REMARK 465 HIS A 180 REMARK 465 THR A 181 REMARK 465 PHE A 182 REMARK 465 PRO A 183 REMARK 465 ALA A 184 REMARK 465 VAL A 185 REMARK 465 LEU A 186 REMARK 465 GLN A 187 REMARK 465 SER A 188 REMARK 465 SER A 189 REMARK 465 GLY A 190 REMARK 465 LEU A 191 REMARK 465 TYR A 192 REMARK 465 SER A 193 REMARK 465 LEU A 194 REMARK 465 SER A 195 REMARK 465 SER A 196 REMARK 465 VAL A 197 REMARK 465 VAL A 198 REMARK 465 THR A 199 REMARK 465 VAL A 200 REMARK 465 PRO A 201 REMARK 465 SER A 202 REMARK 465 SER A 203 REMARK 465 SER A 204 REMARK 465 LEU A 205 REMARK 465 GLY A 206 REMARK 465 THR A 207 REMARK 465 GLN A 208 REMARK 465 THR A 209 REMARK 465 TYR A 210 REMARK 465 ILE A 211 REMARK 465 CYS A 212 REMARK 465 ASN A 213 REMARK 465 VAL A 214 REMARK 465 ASN A 215 REMARK 465 HIS A 216 REMARK 465 LYS A 217 REMARK 465 PRO A 218 REMARK 465 SER A 219 REMARK 465 ASN A 220 REMARK 465 THR A 221 REMARK 465 LYS A 222 REMARK 465 VAL A 223 REMARK 465 ASP A 224 REMARK 465 LYS A 225 REMARK 465 LYS A 226 REMARK 465 VAL A 227 REMARK 465 GLU A 228 REMARK 465 PRO A 229 REMARK 465 LYS A 230 REMARK 465 SER A 231 REMARK 465 CYS A 232 REMARK 465 ASP A 233 REMARK 465 LYS A 234 REMARK 465 THR A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 465 HIS A 240 REMARK 465 HIS A 241 REMARK 465 MET B -18 REMARK 465 GLY B -17 REMARK 465 TRP B -16 REMARK 465 SER B -15 REMARK 465 CYS B -14 REMARK 465 ILE B -13 REMARK 465 ILE B -12 REMARK 465 LEU B -11 REMARK 465 PHE B -10 REMARK 465 LEU B -9 REMARK 465 VAL B -8 REMARK 465 ALA B -7 REMARK 465 THR B -6 REMARK 465 ALA B -5 REMARK 465 THR B -4 REMARK 465 GLY B -3 REMARK 465 VAL B -2 REMARK 465 HIS B -1 REMARK 465 SER B 0 REMARK 465 SER B 1 REMARK 465 TYR B 2 REMARK 465 VAL B 107 REMARK 465 VAL B 108 REMARK 465 GLY B 109 REMARK 465 GLN B 110 REMARK 465 PRO B 111 REMARK 465 LYS B 112 REMARK 465 ALA B 113 REMARK 465 ALA B 114 REMARK 465 PRO B 115 REMARK 465 SER B 116 REMARK 465 VAL B 117 REMARK 465 THR B 118 REMARK 465 LEU B 119 REMARK 465 PHE B 120 REMARK 465 PRO B 121 REMARK 465 PRO B 122 REMARK 465 SER B 123 REMARK 465 SER B 124 REMARK 465 GLU B 125 REMARK 465 GLU B 126 REMARK 465 LEU B 127 REMARK 465 GLN B 128 REMARK 465 ALA B 129 REMARK 465 ASN B 130 REMARK 465 LYS B 131 REMARK 465 ALA B 132 REMARK 465 THR B 133 REMARK 465 LEU B 134 REMARK 465 VAL B 135 REMARK 465 CYS B 136 REMARK 465 LEU B 137 REMARK 465 ILE B 138 REMARK 465 SER B 139 REMARK 465 ASP B 140 REMARK 465 PHE B 141 REMARK 465 TYR B 142 REMARK 465 PRO B 143 REMARK 465 GLY B 144 REMARK 465 ALA B 145 REMARK 465 VAL B 146 REMARK 465 THR B 147 REMARK 465 VAL B 148 REMARK 465 ALA B 149 REMARK 465 TRP B 150 REMARK 465 LYS B 151 REMARK 465 ALA B 152 REMARK 465 ASP B 153 REMARK 465 SER B 154 REMARK 465 SER B 155 REMARK 465 PRO B 156 REMARK 465 VAL B 157 REMARK 465 LYS B 158 REMARK 465 ALA B 159 REMARK 465 GLY B 160 REMARK 465 VAL B 161 REMARK 465 GLU B 162 REMARK 465 THR B 163 REMARK 465 THR B 164 REMARK 465 THR B 165 REMARK 465 PRO B 166 REMARK 465 SER B 167 REMARK 465 LYS B 168 REMARK 465 GLN B 169 REMARK 465 SER B 170 REMARK 465 ASN B 171 REMARK 465 ASN B 172 REMARK 465 LYS B 173 REMARK 465 TYR B 174 REMARK 465 ALA B 175 REMARK 465 ALA B 176 REMARK 465 SER B 177 REMARK 465 SER B 178 REMARK 465 TYR B 179 REMARK 465 LEU B 180 REMARK 465 SER B 181 REMARK 465 LEU B 182 REMARK 465 THR B 183 REMARK 465 PRO B 184 REMARK 465 GLU B 185 REMARK 465 GLN B 186 REMARK 465 TRP B 187 REMARK 465 LYS B 188 REMARK 465 SER B 189 REMARK 465 HIS B 190 REMARK 465 ARG B 191 REMARK 465 SER B 192 REMARK 465 TYR B 193 REMARK 465 SER B 194 REMARK 465 CYS B 195 REMARK 465 GLN B 196 REMARK 465 VAL B 197 REMARK 465 THR B 198 REMARK 465 HIS B 199 REMARK 465 GLU B 200 REMARK 465 GLY B 201 REMARK 465 SER B 202 REMARK 465 THR B 203 REMARK 465 VAL B 204 REMARK 465 GLU B 205 REMARK 465 LYS B 206 REMARK 465 THR B 207 REMARK 465 VAL B 208 REMARK 465 ALA B 209 REMARK 465 PRO B 210 REMARK 465 THR B 211 REMARK 465 GLU B 212 REMARK 465 CYS B 213 REMARK 465 SER B 214 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 106 N - CA - CB ANGL. DEV. = -11.1 DEGREES REMARK 500 LEU B 27 CA - CB - CG ANGL. DEV. = 19.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 54 47.10 -93.87 REMARK 500 PHE A 101 103.70 -163.91 REMARK 500 SER A 104 -128.79 -154.80 REMARK 500 ASP A 105 127.25 -22.33 REMARK 500 PRO A 106 -99.11 24.76 REMARK 500 TYR A 107 99.03 -164.98 REMARK 500 VAL A 108 96.65 -62.67 REMARK 500 ALA B 26 30.48 -94.84 REMARK 500 GLN B 30 147.88 -175.67 REMARK 500 ASP B 50 -16.99 71.75 REMARK 500 THR B 68 52.62 -91.71 REMARK 500 ALA B 92 -7.45 72.75 REMARK 500 VAL F 328 -60.47 -100.84 REMARK 500 ALA F 339 62.14 -102.56 REMARK 500 TYR F 352 -2.81 64.62 REMARK 500 PHE F 364 63.79 36.31 REMARK 500 ALA F 371 -7.94 70.83 REMARK 500 LYS F 373 33.61 -99.55 REMARK 500 ASP F 415 40.37 -108.48 REMARK 500 THR F 425 61.72 -100.42 REMARK 500 TYR F 436 52.68 -92.90 REMARK 500 THR F 486 55.55 -91.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU B 27 PRO B 28 145.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-32719 RELATED DB: EMDB REMARK 900 LOCAL CRYOEM STRUCTURE OF THE SARS-COV S2P IN COMPLEX WITH BD55- REMARK 900 3152 FAB DBREF 7WR9 A -18 241 PDB 7WR9 7WR9 -18 241 DBREF 7WR9 B -18 214 PDB 7WR9 7WR9 -18 214 DBREF 7WR9 F 323 502 UNP P59594 SPIKE_SARS 323 502 SEQRES 1 A 260 MET GLY TRP SER LEU ILE LEU LEU PHE LEU VAL ALA VAL SEQRES 2 A 260 ALA THR ARG VAL LEU SER GLN VAL GLN LEU VAL GLN SER SEQRES 3 A 260 GLY ALA GLU VAL LYS LYS PRO GLY ALA SER VAL ILE VAL SEQRES 4 A 260 SER CYS LYS ALA SER GLY TYR ARG PHE ILE SER HIS TYR SEQRES 5 A 260 ILE HIS TRP VAL ARG GLN ALA PRO GLY GLN GLY LEU GLU SEQRES 6 A 260 TRP MET GLY LYS ILE ASP PRO SER GLY ARG GLY THR THR SEQRES 7 A 260 TYR ALA GLN LYS LEU GLN GLY ARG VAL SER VAL THR ARG SEQRES 8 A 260 ASP THR SER THR SER SER VAL TYR MET ALA LEU SER GLY SEQRES 9 A 260 LEU ARG SER ASP ASP THR ALA VAL TYR TYR CYS ALA ARG SEQRES 10 A 260 ASP ARG PHE PRO LEU SER ASP PRO TYR VAL TRP GLY SER SEQRES 11 A 260 PRO LEU GLY GLY LEU ASP VAL TRP GLY GLN GLY THR THR SEQRES 12 A 260 VAL ILE VAL SER SER ALA SER THR LYS GLY PRO SER VAL SEQRES 13 A 260 PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY SEQRES 14 A 260 THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO SEQRES 15 A 260 GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SEQRES 16 A 260 SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER SEQRES 17 A 260 GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SEQRES 18 A 260 SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN SEQRES 19 A 260 HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU SEQRES 20 A 260 PRO LYS SER CYS ASP LYS THR HIS HIS HIS HIS HIS HIS SEQRES 1 B 233 MET GLY TRP SER CYS ILE ILE LEU PHE LEU VAL ALA THR SEQRES 2 B 233 ALA THR GLY VAL HIS SER SER TYR ASP LEU THR GLN PRO SEQRES 3 B 233 PRO SER VAL SER VAL SER PRO GLY GLN THR ALA ARG ILE SEQRES 4 B 233 THR CYS SER GLY ASP ALA LEU PRO SER GLN TYR VAL TYR SEQRES 5 B 233 TRP TYR GLN GLN ARG PRO GLY GLN ALA PRO VAL LEU VAL SEQRES 6 B 233 MET TYR LYS ASP SER GLU ARG PRO PRO GLY ILE PRO GLU SEQRES 7 B 233 ARG PHE SER GLY SER THR SER GLY THR THR ALA THR LEU SEQRES 8 B 233 THR ILE THR GLY VAL GLN ALA GLU ASP GLU ALA ASP TYR SEQRES 9 B 233 TYR CYS GLN SER ALA ASP ALA SER THR THR TYR HIS VAL SEQRES 10 B 233 PHE GLY GLY GLY THR LYS VAL THR VAL VAL GLY GLN PRO SEQRES 11 B 233 LYS ALA ALA PRO SER VAL THR LEU PHE PRO PRO SER SER SEQRES 12 B 233 GLU GLU LEU GLN ALA ASN LYS ALA THR LEU VAL CYS LEU SEQRES 13 B 233 ILE SER ASP PHE TYR PRO GLY ALA VAL THR VAL ALA TRP SEQRES 14 B 233 LYS ALA ASP SER SER PRO VAL LYS ALA GLY VAL GLU THR SEQRES 15 B 233 THR THR PRO SER LYS GLN SER ASN ASN LYS TYR ALA ALA SEQRES 16 B 233 SER SER TYR LEU SER LEU THR PRO GLU GLN TRP LYS SER SEQRES 17 B 233 HIS ARG SER TYR SER CYS GLN VAL THR HIS GLU GLY SER SEQRES 18 B 233 THR VAL GLU LYS THR VAL ALA PRO THR GLU CYS SER SEQRES 1 F 180 CYS PRO PHE GLY GLU VAL PHE ASN ALA THR LYS PHE PRO SEQRES 2 F 180 SER VAL TYR ALA TRP GLU ARG LYS LYS ILE SER ASN CYS SEQRES 3 F 180 VAL ALA ASP TYR SER VAL LEU TYR ASN SER THR PHE PHE SEQRES 4 F 180 SER THR PHE LYS CYS TYR GLY VAL SER ALA THR LYS LEU SEQRES 5 F 180 ASN ASP LEU CYS PHE SER ASN VAL TYR ALA ASP SER PHE SEQRES 6 F 180 VAL VAL LYS GLY ASP ASP VAL ARG GLN ILE ALA PRO GLY SEQRES 7 F 180 GLN THR GLY VAL ILE ALA ASP TYR ASN TYR LYS LEU PRO SEQRES 8 F 180 ASP ASP PHE MET GLY CYS VAL LEU ALA TRP ASN THR ARG SEQRES 9 F 180 ASN ILE ASP ALA THR SER THR GLY ASN TYR ASN TYR LYS SEQRES 10 F 180 TYR ARG TYR LEU ARG HIS GLY LYS LEU ARG PRO PHE GLU SEQRES 11 F 180 ARG ASP ILE SER ASN VAL PRO PHE SER PRO ASP GLY LYS SEQRES 12 F 180 PRO CYS THR PRO PRO ALA LEU ASN CYS TYR TRP PRO LEU SEQRES 13 F 180 ASN ASP TYR GLY PHE TYR THR THR THR GLY ILE GLY TYR SEQRES 14 F 180 GLN PRO TYR ARG VAL VAL VAL LEU SER PHE GLU HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET FUC C 4 10 HET NAG F 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 4 NAG 3(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 4 FUC C6 H12 O5 HELIX 1 AA1 ARG A 87 THR A 91 5 5 HELIX 2 AA2 ASP F 393 ILE F 397 5 5 HELIX 3 AA3 THR F 425 ALA F 430 1 6 SHEET 1 AA1 2 GLN A 3 GLN A 6 0 SHEET 2 AA1 2 CYS A 22 SER A 25 -1 O LYS A 23 N VAL A 5 SHEET 1 AA2 6 GLU A 10 VAL A 11 0 SHEET 2 AA2 6 THR A 123 ILE A 126 1 O THR A 124 N GLU A 10 SHEET 3 AA2 6 ALA A 92 ALA A 97 -1 N TYR A 94 O THR A 123 SHEET 4 AA2 6 ILE A 34 GLN A 39 -1 N VAL A 37 O TYR A 95 SHEET 5 AA2 6 LEU A 45 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AA2 6 THR A 58 TYR A 60 -1 O THR A 59 N LYS A 50 SHEET 1 AA3 3 VAL A 18 VAL A 20 0 SHEET 2 AA3 3 SER A 78 LEU A 83 -1 O MET A 81 N VAL A 20 SHEET 3 AA3 3 VAL A 68 ASP A 73 -1 N SER A 69 O ALA A 82 SHEET 1 AA4 4 LEU B 4 THR B 5 0 SHEET 2 AA4 4 THR B 17 GLY B 24 -1 O SER B 23 N THR B 5 SHEET 3 AA4 4 THR B 69 THR B 75 -1 O ALA B 70 N CYS B 22 SHEET 4 AA4 4 PHE B 61 THR B 65 -1 N SER B 64 O THR B 71 SHEET 1 AA5 2 SER B 9 VAL B 10 0 SHEET 2 AA5 2 LYS B 104 VAL B 105 1 O LYS B 104 N VAL B 10 SHEET 1 AA6 4 VAL B 44 MET B 47 0 SHEET 2 AA6 4 TYR B 33 GLN B 37 -1 N TRP B 34 O VAL B 46 SHEET 3 AA6 4 ASP B 84 SER B 89 -1 O TYR B 86 N TYR B 35 SHEET 4 AA6 4 VAL B 98 PHE B 99 -1 O VAL B 98 N SER B 89 SHEET 1 AA7 5 GLU F 341 ILE F 345 0 SHEET 2 AA7 5 ASN F 381 LYS F 390 -1 O VAL F 382 N ILE F 345 SHEET 3 AA7 5 PRO F 493 GLU F 502 -1 O VAL F 498 N ASP F 385 SHEET 4 AA7 5 GLY F 418 ASN F 424 -1 N LEU F 421 O VAL F 497 SHEET 5 AA7 5 LYS F 365 TYR F 367 -1 N LYS F 365 O VAL F 420 SHEET 1 AA8 2 LYS F 439 ARG F 441 0 SHEET 2 AA8 2 LEU F 478 ASP F 480 -1 O ASN F 479 N TYR F 440 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.02 SSBOND 2 CYS B 22 CYS B 87 1555 1555 2.03 SSBOND 3 CYS F 323 CYS F 348 1555 1555 2.03 SSBOND 4 CYS F 366 CYS F 419 1555 1555 2.03 SSBOND 5 CYS F 467 CYS F 474 1555 1555 2.03 LINK ND2 ASN F 330 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN F 357 C1 NAG F 601 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O6 NAG C 1 C1 FUC C 4 1555 1555 1.44 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.45 CISPEP 1 PRO F 469 PRO F 470 0 0.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000